Rhessa Diaz

Senior Manager of Cell Therapy Analysis • Bristol Myer Squibb

Rhessa has 20+ years of flow cytometry experience.  She has worked at BD Biosciences as a Senior Flow Cytometry Instructor and Field Application Scientist with both clinical and research applications.  Her experience in CAR-T Cell Therapy began with Juno Therapeutics in 2015 as a QC Scientist which involved method transfer and lifecycle management for RFI (release for infusion) methods for CAR-T Cellular therapies to multiple GMP sites. She serves as an SME for flow cytometry assays and instrumentation and lead efforts in troubleshooting assays and data analysis to support clinical programs. Rhessa has had roles in analytical development and method qualification for both early and late-stage programs.  Currently at BMS, she is a technical steward for development and implementation of new technology platforms in the Custom and Process Analytics group.

Also Speaking

Ludwig Camusot

Chief Corporate Development Officer • Cell Matters

Hanna Lesch

Chief Technology Officer • Exothera

Tania D. Pereira Chilima

Chief Technology Officer • Univercells Technologies

Event Info


Fun Run